Prosecution Insights
Last updated: October 04, 2026

Daesang Corporation

Technology area: Biotechnology & Pharmaceuticals

9 pending office actions • 6 art units • 8 examiners • 0 of 9 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
4
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
0
Due this month
2
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (33%)
5
Medium (56%)
0
Easy (0%)
1
Unknown (11%)

Rejection Statute Mix

BucketCases
§101 + other1 (11%)
§103 only2 (22%)
§102 only1 (11%)
Double-patenting + other2 (22%)
Multi-statute (no §101)2 (22%)
No statute on record1 (11%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PAK, YONG D 2 74.6% +14.3%
KIEFER, DALTON EDWARD 1 83.3% +0.0%
KUBELIK, ANNE R 1 75.8% -0.7%
DAVIS, RUTH A 1 60.8% +31.1%
NOAKES, SUZANNE MARIE 1 73.3% +18.2%
YAMASAKI, ROBERT J 1 67.6% +43.7%
CONSTANTINE, CHARLES Z 1 58.9% +49.2%
DIVIESTI, KARLA ISOBEL 1 3.4% +20.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18993136 MUTATED MICROORGANISM OF GENUS CORYNEBACTERIUM WHICH PRODUCES L-GLUTAMIC ACID AND METHOD FOR PRODUCING L-GLUTAMIC ACID USING SAME KIEFER, DALTON EDWARD —

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18269694 ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME CONSTANTINE, CHARLES Z 34d
18993134 CORYNEBACTERIUM SP. MUTANT MICROORGANISM PRODUCING L-GLUTAMIC ACID AND METHOD FOR PRODUCING L-GLUTAMIC ACID USING SAME KUBELIK, ANNE R —
18269647 ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME NOAKES, SUZANNE MARIE —
18004600 COMPOSITION FOR PRODUCING PROTEIN NOODLES WITH IMPROVED MOUTHFEEL, METHOD FOR PRODUCING PROTEIN NOODLES USING SAME, AND PROTEIN NOODLES PRODUCED BY USING SAME DIVIESTI, KARLA ISOBEL —

Interview Candidates (7)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.

App #TitleExaminerDue in
18269694 ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME CONSTANTINE, CHARLES Z 34d
18269683 ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME YAMASAKI, ROBERT J 49d
18713941 CORYNEBACTERIUM GLUTAMICUM VARIANT HAVING IMPROVED L-LYSINE PRODUCTION ABILITY AND METHOD FOR PRODUCING L-LYSINE BY USING SAME DAVIS, RUTH A —
18269647 ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME NOAKES, SUZANNE MARIE —
18269666 ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME PAK, YONG D —
18269689 ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME PAK, YONG D —
18004600 COMPOSITION FOR PRODUCING PROTEIN NOODLES WITH IMPROVED MOUTHFEEL, METHOD FOR PRODUCING PROTEIN NOODLES USING SAME, AND PROTEIN NOODLES PRODUCED BY USING SAME DIVIESTI, KARLA ISOBEL —

Top Art Units

Art UnitApps
1652 3
1657 2
1663 1
1699 1
1656 1
1792 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18993136 MUTATED MICROORGANISM OF GENUS CORYNEBACTERIUM WHICH PRODUCES L-GLUTAMIC ACID AND METHOD FOR PRODUCING L-GLUTAMIC ACID USING SAME KIEFER, DALTON EDWARD 1652 §102 Non-Final OA — Pending Jan 10, 2025
18993134 CORYNEBACTERIUM SP. MUTANT MICROORGANISM PRODUCING L-GLUTAMIC ACID AND METHOD FOR PRODUCING L-GLUTAMIC ACID USING SAME KUBELIK, ANNE R 1663 §101§112 Non-Final OA — Pending Jan 10, 2025
18713941 CORYNEBACTERIUM GLUTAMICUM VARIANT HAVING IMPROVED L-LYSINE PRODUCTION ABILITY AND METHOD FOR PRODUCING L-LYSINE BY USING SAME DAVIS, RUTH A 1699 §103 Final Rejection — Pending May 28, 2024
18269647 ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME NOAKES, SUZANNE MARIE 1656 §103§112 Non-Final OA — Pending Jul 18, 2023
18269683 ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME YAMASAKI, ROBERT J 1657 Other Non-Final OA 49d Pending Jul 18, 2023
18269666 ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME PAK, YONG D 1652 §103§112DP Final Rejection — Pending Jun 26, 2023
18269694 ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME CONSTANTINE, CHARLES Z 1657 §102§103Other Final Rejection 34d Pending Jun 26, 2023
18269689 ATP-PRT VARIANT WITH REDUCED FEEDBACK INHIBITION BY HISTIDINE, AND HISTIDINE-PRODUCING STRAIN EXPRESSING SAME PAK, YONG D 1652 §103§112DP Final Rejection — Pending Jun 26, 2023
18004600 COMPOSITION FOR PRODUCING PROTEIN NOODLES WITH IMPROVED MOUTHFEEL, METHOD FOR PRODUCING PROTEIN NOODLES USING SAME, AND PROTEIN NOODLES PRODUCED BY USING SAME DIVIESTI, KARLA ISOBEL 1792 §103 Final Rejection — Pending Jan 06, 2023

Managing Daesang Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month